Source link : https://newshealth.biz/health-news/nemolizumab-shows-lasting-benefits-in-prurigo-nodularis/
TOPLINE: Nemolizumab was well tolerated and provided lasting relief from itching and disease severity while improving quality of life in patients with prurigo nodularis (PN) over 68 weeks. Patients also decreased their use of topical corticosteroids. METHODOLOGY: A Japanese phase 2/3 randomized, double-blind, placebo-controlled study enrolled 226 Asian patients aged ≥ 13 years with PN […]
The post Nemolizumab Shows Lasting Benefits in Prurigo Nodularis first appeared on News Health.
Author : News Health
Publish date : 2025-03-25 11:13:00
Copyright for syndicated content belongs to the linked Source.
in Health